Skip to Content

COVID-19 Info: Please help us slow the spread of coronavirus - Wear a Mask, Wash Your Hands & Wait 6 Feet Apart!
Visitor Policies and Precautions | COVID-19 Testing| Vaccine information | Commitment to Safety | Current Numbers

Clinical Trials Details

ACTG study A5359

ACTG study A5359: A Phase III Study to Evaluate Long-Acting Antiretroviral Therapy in Non-Adherent HIV-Infected Individuals

Patient Information

This study will compare the efficacy, safety and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy with rilpivirine (RPV) LA and cabotegravir (CAB) LA versus all-oral standard of care (SOC). More details can be found here.

Clinical Trial Categories

  • HIV / AIDS


  • Regional Center for Infectious Disease
    301 E. Wendover Ave.
    Ste 111
    Greensboro, NC 27401
    Main: 336-832-7840
    Fax: 336-832-3285